New facility supports University of Montreal researchers with advanced imaging tools WALTHAM, Mass. — Olympus continues to demonstrate its commitment to advancing bioscience research with the opening of the new Olympus Discovery Center at the University of Montreal’s Centre interdisciplinaire de recherche sur le cerveau et l’apprentissage (Center for Interdisciplinary Research on Brain and Learning, […]

London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors. Dr Jenkins brings over 30 years of global industry experience to RevoluGen’s board, with expertise in scientific research, genomics, regulatory approval and healthcare systems. She is currently a board […]

We are glad to announce that we have reached a settlement with Organovo in which we agreed to resolve all aspects of the disputes between the parties. Organovo and BICO were engaged in several legal disputes regarding Organovo’s patents. Under the new agreement, all civil actions regarding potential infringements and IPRs concerning validity of Organovo’s patents are […]

Fully automated GeoMx RNA workflow reduces hands-on time, allowing users to prepare up to 30 slides in one day with high reproducibility SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of a fully automated GeoMx® RNA protocol on BOND RX […]

MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology. Michael will be responsible for leading the company’s bioinformatics and data sciences program to enhance PacBio’s genomic analysis offerings. Michael is a genomics industry veteran with more than 20 years […]

Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory […]

LIMERICK, PA Rockland Immunochemicals, Inc. (Rockland), a leading life science reagents manufacturer and service provider with years of expertise in antibodies, assay, and reagent development for early- to late-stage bioprocessing and the Jefferson Institute for Bioprocessing (JIB), a full-service development and training organization specializing in biologics and biopharmaceuticals announced today that an agreement has been signed […]

BOSTON, United States, LAUSANNE, Switzerland, and HIROSHIMA, Japan – SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with Hiroshima University, one of the top public universities in Hiroshima City, Japan, to support their molecular profiling by next-generation sequencing (NGS) in investigating the pathogenic variants causing different blood cancer disorders. Hiroshima University is home to one of […]

Element Biosciences and Agilent Technologies have integrated Element’s AVITI System with Agilent’s SureSelect target enrichment panels. Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Agilent Technologies demonstrating the integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic […]

This partnership integrates the performance, cost, and flexibility of the Element AVITI System with New England Biolabs’ powerful NEBNext Ultra II library prep technology to provide a unique end-to-end solution for Element sequencing customers and further expand the well-established NEBNext Ultra II technology. Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, […]